These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8232904)

  • 1. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.
    Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study.
    Morris BJ; Herz A; Höllt V
    J Mol Neurosci; 1989; 1(1):9-18. PubMed ID: 2561993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion.
    Nisenbaum LK; Kitai ST; Crowley WR; Gerfen CR
    Neuroscience; 1994 Jun; 60(4):927-37. PubMed ID: 7523989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat.
    Chritin M; Feuerstein C; Savasta M
    Brain Res Mol Brain Res; 1993 Sep; 19(4):318-22. PubMed ID: 8231735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor (NGF) potentiates the changes in striatal proenkephalin mRNAs subsequent to 6-hydroxydopamine-induced lesions of the substantia nigra.
    Cadet JL; Angulo JA; McEwen BS
    Brain Res Bull; 1990 Sep; 25(3):401-5. PubMed ID: 2127237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.
    Eghbali M; Santoro C; Paredes W; Gardner EL; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6582-6. PubMed ID: 2819882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J; Rogard M; Besson MJ
    Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata.
    Wang H; Katz J; Dagostino P; Soghomonian JJ
    Neuroscience; 2007 Mar; 145(2):727-37. PubMed ID: 17218060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
    Eur J Neurosci; 1996 Dec; 8(12):2511-20. PubMed ID: 8996800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
    Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.
    Romero J; Berrendero F; Pérez-Rosado A; Manzanares J; Rojo A; Fernández-Ruiz JJ; de Yebenes JG; Ramos JA
    Life Sci; 2000; 66(6):485-94. PubMed ID: 10794065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.